SignatureFD’s Collegium Pharmaceutical COLL Stock Holding History

SignatureFD’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$131	Sell	6 -80	-93%	-$2.34K	﹤0.01%	3487
2026 Q2	$3.11K	Sell	86 -155	-64%	-$5.3K	﹤0.01%	3020
2026 Q1	$7.97K	Hold	241	–	–	﹤0.01%	2606
2025 Q4	$11.2K	Buy	241 +148	+159%	+$6.19K	﹤0.01%	2383
2025 Q3	$3.25K	Buy	93 +81	+675%	+$2.82K	﹤0.01%	2801
2025 Q2	$355	Sell	12 -82	-87%	-$2.34K	﹤0.01%	3151
2025 Q1	$2.81K	Buy	94 +33	+54%	+$1.01K	﹤0.01%	2786
2024 Q4	$1.75K	Sell	61 -150	-71%	-$4.96K	﹤0.01%	2911
2024 Q3	$8.15K	Buy	211 +150	+246%	+$5.35K	﹤0.01%	2416
2024 Q2	$1.96K	Sell	61 -62	-50%	-$2.15K	﹤0.01%	2760
2024 Q1	$4.78K	Buy	123 +52	+73%	+$1.82K	﹤0.01%	2554
2023 Q4	$2.18K	Hold	71	–	–	﹤0.01%	2732
2023 Q3	$1.59K	Hold	71	–	–	﹤0.01%	2835
2023 Q2	$1.53K	Sell	71 -13	-15%	-$295	﹤0.01%	2878
2023 Q1	$2.02K	Hold	84	–	–	﹤0.01%	2798
2022 Q4	$1.95K	Buy	84 +13	+18%	+$262	﹤0.01%	2822
2022 Q3	$1K	Sell	71 -66	-48%	-$1.16K	﹤0.01%	2931
2022 Q2	$2K	Buy	137 +100	+270%	+$1.68K	﹤0.01%	2721
2022 Q1	$1K	Buy	+37	New	+$699	﹤0.01%	2962

Other funds holding COLL

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Ballast Asset Management Dallas, Texas $230M AUM 34.36% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

SignatureFD's COLL Position: Q3 2026 in Review

SignatureFD reduced its Collegium Pharmaceutical (COLL) stake by 93% in Q3 2026, selling an estimated $2.34K and leaving 6 shares worth $131. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

SignatureFD first reported a position in COLL in Q1 2022 and has held it in 19 quarters since. The position peaked at $11.2K in Q4 2025. 91 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

SignatureFD held 6 shares of Collegium Pharmaceutical worth $131 as of Q3 2026.
SignatureFD sold 80 Collegium Pharmaceutical shares in Q3 2026, an estimated $2.34K.
Collegium Pharmaceutical made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3487 holding.
SignatureFD first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 19 quarters since.
SignatureFD's Collegium Pharmaceutical position peaked at $11.2K in Q4 2025.
91 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.